Weight loss after initiating anti-obesity medications and gout among overweight and obesity individuals: a population-based cohort study.

Yuqing ZhangYilun WangNicola DalbethJunqing XieJing WuChao ZengGuang-Hua Lei Yuqing Zhang

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2024)

A higher rate of weight loss after initiating orlistat within 1-year was associated with lower risks of incident gout and lower rates of recurrent gout flares among overweight or obese people.

Keyphrases

weight loss
uric acid
bariatric surgery
roux en y gastric bypass
gastric bypass
metabolic syndrome
weight gain
glycemic control
cardiovascular disease
type diabetes
risk assessment